A Solini, L Vergnani, F Ricci, G Crepaldi - Diabetes Care, 1997 - Am Diabetes Assoc OBJECTIVE: To determine the effect of oral administration of glycosaminoglycans
on metabolic control and albumin excretion rate (AER) in NIDDM patients with
increased urinary albumin excretion. RESEARCH DESIGN AND METHODS: Twelve ... Cited by 45 - Related articles - BL Direct - All 6 versions
- ►oxfordjournals.org [PDF] I Dedov, M Shestakova, A Vorontzov, E … - Nephrology Dialysis Transplantation, 1997 - ERA-EDTA Page 1. Nephrol Dial Transplant (1997) 12: 2295–2300 Nephrology Dialysis
Transplantation Original Article A randomized, controlled ... Cited by 30 - Related articles - BL Direct - All 4 versions
A Poplawska, M Szelachowska, J Topolska, B … - Diabetes research and clinical practice, 1997 - Elsevier The aim of this study was to investigate whether sulodexide treatment is capable
of influencing urinary albumin excretion rate (UAER) in insulin-dependent
diabetes mellitus patients (type I) with micro- or macroalbuminuria. A ... Cited by 15 - Related articles - All 7 versions
B Myrup, PM Hansen, T Jensen, A Kofoed- … - Lancet, 1995 - ncbi.nlm.nih.gov We investigated the effect of heparin on urinary albumin excretion in patients
with insulin-dependent diabetes mellitus. 39 patients with persistent urinary
albumin excretion of 30-300 mg/24 h were randomly treated for 3 months with ... Cited by 65 - Related articles - BL Direct - All 3 versions
M Velussi, AM Cernigoi, F Dapas, A De Monte - Diabetes, nutrition & metabolism(Testo stampato), 1996 - cat.inist.fr Glycosaminoglycans oral therapy reduces microalbuminuria, blood fibrinogen levels
and limb arteriopathy clinical signs in patients with non-insulin dependent ... Cited by 13 - Related articles - BL Direct
J Škrha, J Perušičová, P Pont'uch, A Okša - Diabetes research and clinical practice, 1997 - Elsevier ОЩПШ, МАСТГЮЕ ELSEVIER Diabetes Research and Clinical Practice 38
(1997) 25-31 ==== Glycosaminoglycan sulodexide decreases albuminuria in diabetic
patients J. Skrha a>*, J. Perusicová b, P. Pont'uchc, A. Oksa d a ... Cited by 22 - Related articles - All 6 versions
G Gambaro, AP Venturini, DM Noonan, W Fries, … - Kidney international, 1994 - nature.com Treatment with a glycosaminoglycan formulation ameliorates experimental diabetic
nephropathy. Previous studies have indicated that administration of
glycosaminoglycans can prevent some of the morphological and physiological ... Cited by 82 - Related articles - BL Direct - All 4 versions
- ►asnjournals.org [PDF] JW Van der Pijl, FJ Van der Woude, PH … - Journal of the American Society of Nephrology, 1997 - Am Soc Nephrol Page 1. Danaparoid Sodium Lowers Proteinuria in Diabetic Nephropathy JOHAN W. VAN
DER PIJL,* FOKKO J. VAN DER WOUDE,* PETRONELLA HLM GEELHOEDDUIJVESTIJN,t ... Cited by 27 - Related articles - BL Direct - All 9 versions
M Szelanowska, A Poplawska, J Jopdska, I … - Current medical research and opinion, 1997 - informahealthcare.com A pilot study of the effect of the glycosaminoglycan sulodexide on
microalbuminuria in type I diabetic patients ... M. Szelanowska", MD, A.
Poplawska*, MD, J. Jopdska", MD, I. Kinalska*, MD and M. Grimaldit, MD Cited by 15 - Related articles - BL Direct - All 5 versions
- ►asnjournals.org M CEOL, G GAMBARO, U SAUER, B BAGGIO, … - Journal of the American Society of Nephrology, 2000 - Am Soc Nephrol Abstract. Chronic induction of the prosclerotic cytokine transforming growth
factor ß (TGF-ß) has been implicated in the pathogenesis of diabetic
nephropathy. In a rat model of diabetes mellitus-induced ... Cited by 38 - Related articles - BL Direct - All 5 versions
